Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
278 EUR | -1.19% | +2.53% | +0.04% |
06-12 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377, Maintains Outperform Rating | MT |
06-12 | BMO Capital Adjusts Price Target on Sherwin-Williams to $360 From $377 | MT |
Strengths
- The opinion of analysts covering the stock has improved over the past four months.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 3.64 times the sales for the current fiscal year, the company turns out to be overvalued.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Commodity Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+0.04% | 76.14B | - | ||
-15.01% | 33.58B | B- | ||
-14.50% | 30.09B | A- | ||
-7.81% | 15.63B | B | ||
+0.22% | 14.41B | B+ | ||
-21.38% | 10.83B | B+ | ||
+1.85% | 7.63B | B- | ||
-17.64% | 7.05B | B | ||
+6.83% | 3.42B | B- | ||
-14.43% | 3.04B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SHW Stock
- SJ3 Stock
- Ratings The Sherwin-Williams Company